報價延遲最少15分鐘:2025/02/23 03:48 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
7.45 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.72/-0.29
|
|
企業價值
454.58M
|
| 資產負債 |
|
每股賬面淨值
1.64
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
36.68M
|
|
每股收益
0.74
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/23 03:48 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States. |